← Back to Clinical Trials
Recruiting NCT06117176

NCT06117176 Prospective Assessment Project of AirwaY Management-related Incidents in Adult Anaesthesia Care PAPAYA III

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06117176
Status Recruiting
Phase
Sponsor Insel Gruppe AG, University Hospital Bern
Condition Airway Complication of Anesthesia
Study Type OBSERVATIONAL
Enrollment 40,000 participants
Start Date 2025-02-01
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 40,000 participants in total. It began in 2025-02-01 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The overall objective of the study is to evaluate and analyze major and minor incidents during airway management in adults under anaesthesia care at all study sites. The patient characteristics, type of airway management is recorded and if airway management-related incidents occur, they are analyzed in more detail to improve patient safety in the future.

Eligibility Criteria

Inclusion Criteria: * All adult patients requiring airway management under anaesthesia care for elective, semi-elective, urgent or emergency diagnostic procedures or interventions. Airway management includes awake and asleep tracheal intubation, insertion of supraglottic airway devices, and face mask ventilation. * Patients older than 18 years of age * Informed consent given or general consent in place, according to local ethics committee requirements. Exclusion Criteria: * Refusal to give consent or withdrawal of consent. * Patients \<18 years.

Contact & Investigator

Central Contact

Thomas Riva, MD,PD

✉ thomas.riva@insel.ch

📞 +41 31 632 21 11

Principal Investigator

Robert Greif, MD, Prof

STUDY CHAIR

Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University

Frequently Asked Questions

Who can join the NCT06117176 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Airway Complication of Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06117176 currently recruiting?

Yes, NCT06117176 is actively recruiting participants. Contact the research team at thomas.riva@insel.ch for enrollment information.

Where is the NCT06117176 trial being conducted?

This trial is being conducted at Berlin, Germany, Hamburg, Germany, Bern, Switzerland, Aarau, Switzerland and 1 additional location.

Who is sponsoring the NCT06117176 clinical trial?

NCT06117176 is sponsored by Insel Gruppe AG, University Hospital Bern. The principal investigator is Robert Greif, MD, Prof at Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University. The trial plans to enroll 40,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology